TScan Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 0.1949 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 13.21M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company’s lead product is TSC-101, for the treatment of patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and acute lymphoblastic leukemia (ALL) in patients undergoing allogeneic hematopoietic cell transplantation (HCT), which is in Phase I clinical trial, as well as eliminates residual disease and promotes donor chimerism. It also develops TSC-102-A01 and TSC-102-A03, which are allogeneic and donor-derived TCR-T therapy candidates targeting epitopes. In addition, the company develops TSC-200, TSC-201, TSC-202, TSC-203, and TSC-204 for the treatment of solid tumors. It has a research collaboration and license agreement with Amgen Inc. to identify antigens recognized by T cells in patients with Crohn’s disease. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
Details
| Name | TScan Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 138 |
| Founded | 2018 |
| Ipo Date | 2021-07-16 |
| Ceo | Gavin MacBeath |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 15.00 |
| Isin | US89854M1018 |
| Cusip | 89854M101 |
| Cik | 1783328 |
| Sic | 2836 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Gavin MacBeath Ph.D. | Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer and Director |
| Dr. Stephen J. Elledge Ph.D. | Co-Founder and Chairman of Scientific Advisory Board |
| Tomasz Kula Ph.D. | Co-Founder and Member of Advisory Board |
| Dr. Zoran Zdraveski J.D., Ph.D. | Chief Legal and Strategy Officer and Company Secretary |
| Ann Hargraves | Chief Human Resources Officer |
| Dr. Shrikanta Chattopadhyay M.D. | Senior Vice President and Head of Translational Medicine |
| Jim Murray | Chief Development Operations Officer |
| Cagan Gurer Ph.D. | Senior Vice President of Discovery |
Contact
| Address | 830 Winter Street, Waltham, Massachusetts 02451, United States |
| Phone | 857 399 9500 |
| Website | https://www.tscan.com |